Literature DB >> 3534435

Mouse strain difference in bile duct lesions induced by swine serum injections.

K Imaoka, K Doi, C Doi, W Toriumi, K Honjo, T Mitsuoka.   

Abstract

The mouse strain difference in bile duct lesions was studied on male A/J, BALB/c, C57BL/6, C3H/He, DBA/2 and DDY mice 4 weeks old given intraperitoneal injections of swine serum (0.05 or 0.2 ml per mouse) twice a week for 4 weeks. The hepatic lesions were restricted to the portal tract. Biliary epithelial cells showed hypertrophy and hyperplasia, and eosinophilic and homogeneous or needle-shaped material appeared in the cytoplasm of such hypertrophied epithelial cells and in the ductular lumen. Around these damaged biliary epithelia, eosinophil leukocyte and plasma cell infiltration with proliferation of collagen fibres was commonly detected. These changes became more apparent with increasing size of bile duct. Such histopathological characteristics of hepatic lesions were essentially the same in all strains, but the severity showed a clear strain difference: the lesion was marked in the DDY, A/J and BALB/c strains, moderate in C3H/He and slight in C57BL/6 and DBA/2. A high production of anti-swine-serum antibodies associated with a marked increase in the number of mouse IgG-producing lymphocytes in the spleen was detected in the strains showing the marked hepatic lesions.

Entities:  

Mesh:

Year:  1986        PMID: 3534435     DOI: 10.1258/002367786780808686

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  3 in total

1.  Factors influencing the incidence and severity of swine-serum-induced bile duct lesion in mice.

Authors:  K Doi; K Honjo; S Itagaki; C Doi; T Mitsuoka
Journal:  Br J Exp Pathol       Date:  1987-08

2.  Histochemical characteristics of glycoproteins in the bile duct system of mice immunized with swine serum.

Authors:  S Itagaki; K Honjo; K Doi; T Mitsuoka
Journal:  Histochemistry       Date:  1988

3.  Molecular pathology of murine ureteritis causing obstructive uropathy with hydronephrosis.

Authors:  Osamu Ichii; Saori Otsuka; Yuka Namiki; Yoshiharu Hashimoto; Yasuhiro Kon
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.